328 related articles for article (PubMed ID: 35742999)
1. Role of the Ribonuclease ONCONASE in miRNA Biogenesis and tRNA Processing: Focus on Cancer and Viral Infections.
Menegazzi M; Gotte G
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742999
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of miR-34a-5p, miR-20a-3p and miR-29a-3p by Onconase in A375 Melanoma Cells Correlates with the Downregulation of Specific Onco-Proteins.
De Tomi E; Campagnari R; Orlandi E; Cardile A; Zanrè V; Menegazzi M; Gomez-Lira M; Gotte G
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163570
[TBL] [Abstract][Full Text] [Related]
3. The cytotoxic ribonuclease onconase targets RNA interference (siRNA).
Zhao H; Ardelt B; Ardelt W; Shogen K; Darzynkiewicz Z
Cell Cycle; 2008 Oct; 7(20):3258-61. PubMed ID: 18927512
[TBL] [Abstract][Full Text] [Related]
4. Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity.
Fernández-Ulibarri I; Hammer K; Arndt MA; Kaufmann JK; Dorer D; Engelhardt S; Kontermann RE; Hess J; Allgayer H; Krauss J; Nettelbeck DM
Int J Cancer; 2015 May; 136(9):2228-40. PubMed ID: 25303768
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic ribonucleases and RNA interference (RNAi).
Ardelt B; Ardelt W; Darzynkiewicz Z
Cell Cycle; 2003; 2(1):22-4. PubMed ID: 12695680
[TBL] [Abstract][Full Text] [Related]
6. Constitutive expression and anticancer potency of a novel immunotoxin onconase-DV3.
Sun M; Tang H; Gao Y; Dai X; Yuan Y; Zhang C; Sun D
Oncol Rep; 2016 Apr; 35(4):1987-94. PubMed ID: 26782924
[TBL] [Abstract][Full Text] [Related]
7. Combination of onconase and dihydroartemisinin synergistically suppresses growth and angiogenesis of non-small-cell lung carcinoma and malignant mesothelioma.
Shen R; Li J; Ye D; Wang Q; Fei J
Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):894-901. PubMed ID: 27590062
[TBL] [Abstract][Full Text] [Related]
8. The crystal structure of the domain-swapped dimer of onconase highlights some catalytic and antitumor activity features of the enzyme.
Gotte G; Campagnari R; Loreto D; Bettin I; Calzetti F; Menegazzi M; Merlino A
Int J Biol Macromol; 2021 Nov; 191():560-571. PubMed ID: 34563576
[TBL] [Abstract][Full Text] [Related]
9. Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.
Ardelt W; Shogen K; Darzynkiewicz Z
Curr Pharm Biotechnol; 2008 Jun; 9(3):215-25. PubMed ID: 18673287
[TBL] [Abstract][Full Text] [Related]
10. Influence of onconase in the therapeutic potential of PARP inhibitors in A375 malignant melanoma cells.
Raineri A; Prodomini S; Fasoli S; Gotte G; Menegazzi M
Biochem Pharmacol; 2019 Sep; 167():173-181. PubMed ID: 31185226
[TBL] [Abstract][Full Text] [Related]
11. Onconase dimerization through 3D domain swapping: structural investigations and increase in the apoptotic effect in cancer cells.
Fagagnini A; Pica A; Fasoli S; Montioli R; Donadelli M; Cordani M; Butturini E; Acquasaliente L; Picone D; Gotte G
Biochem J; 2017 Nov; 474(22):3767-3781. PubMed ID: 28963346
[TBL] [Abstract][Full Text] [Related]
12. Entry into cells and selective degradation of tRNAs by a cytotoxic member of the RNase A family.
Saxena SK; Sirdeshmukh R; Ardelt W; Mikulski SM; Shogen K; Youle RJ
J Biol Chem; 2002 Apr; 277(17):15142-6. PubMed ID: 11839736
[TBL] [Abstract][Full Text] [Related]
13. Identification and functional characterization of tRNA-derived RNA fragments (tRFs) in respiratory syncytial virus infection.
Wang Q; Lee I; Ren J; Ajay SS; Lee YS; Bao X
Mol Ther; 2013 Feb; 21(2):368-79. PubMed ID: 23183536
[TBL] [Abstract][Full Text] [Related]
14. Onconase cytotoxicity relies on the distribution of its positive charge.
Turcotte RF; Lavis LD; Raines RT
FEBS J; 2009 Jul; 276(14):3846-57. PubMed ID: 19523116
[TBL] [Abstract][Full Text] [Related]
15. Contribution of active-site residues to the function of onconase, a ribonuclease with antitumoral activity.
Lee JE; Raines RT
Biochemistry; 2003 Oct; 42(39):11443-50. PubMed ID: 14516195
[TBL] [Abstract][Full Text] [Related]
16. Role of the tRNA-Derived Small RNAs in Cancer: New Potential Biomarkers and Target for Therapy.
Balatti V; Pekarsky Y; Croce CM
Adv Cancer Res; 2017; 135():173-187. PubMed ID: 28882222
[TBL] [Abstract][Full Text] [Related]
17. Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines.
Ita M; Halicka HD; Tanaka T; Kurose A; Ardelt B; Shogen K; Darzynkiewicz Z
Cancer Biol Ther; 2008 Jul; 7(7):1104-8. PubMed ID: 18443430
[TBL] [Abstract][Full Text] [Related]
18. tRNA-derived fragments: Mechanisms underlying their regulation of gene expression and potential applications as therapeutic targets in cancers and virus infections.
Yu X; Xie Y; Zhang S; Song X; Xiao B; Yan Z
Theranostics; 2021; 11(1):461-469. PubMed ID: 33391486
[TBL] [Abstract][Full Text] [Related]
19. Onconase action on tRNA(Lys3), the primer for HIV-1 reverse transcription.
Suhasini AN; Sirdeshmukh R
Biochem Biophys Res Commun; 2007 Nov; 363(2):304-9. PubMed ID: 17888404
[TBL] [Abstract][Full Text] [Related]
20. Anti-gliomas Effect of Chlorotoxin-Conjugated Onconase at High Dose.
Wang X; Guo Z
Cell Biochem Biophys; 2015 Nov; 73(2):389-392. PubMed ID: 27352327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
